神经退行性变
化学
神经保护
神经科学
神经炎症
疾病
大麻素受体2型
大麻素受体
药理学
受体
兴奋剂
医学
心理学
生物化学
内科学
作者
Francesco Spinelli,Elena Capparelli,Carmen Abate,Nicola Antonio Colabufo,Marialessandra Contino
标识
DOI:10.1021/acs.jmedchem.7b00155
摘要
Up-regulation of CB2R on activated microglial cells, the first step in neurodegeneration, has been widely demonstrated, and this finding makes the receptor a promising target in the early diagnosis and treatment of several neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and multiple sclerosis (MS). The development of CB2R PET ligands could help demonstrate the neurodegenerative pathogenesis, thus providing useful tools for characterizing the role of neuroinflammation in the progression of these disorders. CB2R agonists and inverse agonists have emerged as neuroprotective agents, and CB2R agonists have entered several clinical trials. CB2R ligands have therefore received great attention, and different molecular scaffolds have been selected to target CB2R subtypes. This review is focused on structure-activity relationship (SAR) and structure-affinity relationship (SAfiR) studies performed on different scaffolds with the aim to identify the molecular features useful for the design of both therapeutic and diagnostic agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI